Korean J Med.
2015 Sep;89(3):368-371. 10.3904/kjm.2015.89.3.368.
A Case of Zonisamide-Induced Stevens-Johnson Syndrome
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. jhleemd@yuhs.ac
- 2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.
- 3Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
- KMID: 2269015
- DOI: http://doi.org/10.3904/kjm.2015.89.3.368
Abstract
- Stevens-Johnson syndrome (SJS) is a rare but severe disorder typically caused by medications and characterized by mucocutaneous eruptions. Zonisamide is an antiepileptic drug that is structurally different from other drugs of the same class. It is considered safe for patient use, and few cases describing severe cutaneous adverse reactions from zonisamide have been reported. We herein report a case of zonisamide-induced SJS in a 36-year-old woman. The patient presented with a widespread erythematous maculopapular rash after taking zonisamide. The symptoms of SJS improved after zonisamide was discontinued and systemic steroids and intravenous immunoglobulins were administered. This is the first case of zonisamide-induced SJS in Korea. Although this drug is generally considered safe, we suggest that clinicians be aware of potential adverse reactions, including SJS.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Stevens-Johnson Syndrome in a Hypoxic Brain Injury Patient Treated with Carbamazepine
- Five Cases of Stevens-Johnson Syndrome May Be Associated with Methazolamide Treatment
- Clinical Study of Stevens-Johnson Syndrome
- A Case of High Dose Cytosine Arabinoside Induced Stevens-Johnson Syndrome in a Patient with Malignant Lymphoma
- A Case of Secondary Milia Associated with Stevens-Johnson Syndrome
